A total of 12 (75%) BAG3-NMD patients, all of them carrying the p.(Pro209Leu) variant, developed a restrictive cardiomyopathy, associated with heart failure symptoms despite a preserved systolic function. The gene discussed is BAG3; the disease is heart failure.